BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Sold by Amplius Wealth Advisors LLC

Amplius Wealth Advisors LLC cut its stake in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 22.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,665 shares of the company’s stock after selling 8,133 shares during the period. Amplius Wealth Advisors LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $472,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Prevail Innovative Wealth Advisors LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at about $1,452,000. Almitas Capital LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at approximately $728,000. Oppenheimer & Co. Inc. boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 18.6% in the first quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after acquiring an additional 4,586 shares during the period. Virtu Financial LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the fourth quarter worth approximately $315,000. Finally, Quarry LP increased its holdings in shares of BlackRock Capital Allocation Term Trust by 68.4% in the 2nd quarter. Quarry LP now owns 69,034 shares of the company’s stock valued at $1,133,000 after acquiring an additional 28,045 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

Insider Transactions at BlackRock Capital Allocation Term Trust

In related news, major shareholder Saba Capital Management, L.P. sold 15,894 shares of the business’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $16.41, for a total value of $260,820.54. Following the transaction, the insider now owns 16,317,706 shares in the company, valued at $267,773,555.46. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last quarter, insiders sold 616,314 shares of company stock worth $10,172,244.

BlackRock Capital Allocation Term Trust Trading Up 0.1 %

BCAT stock opened at $16.26 on Thursday. BlackRock Capital Allocation Term Trust has a 12 month low of $13.67 and a 12 month high of $17.18. The company has a fifty day moving average price of $16.36 and a 200 day moving average price of $16.26.

BlackRock Capital Allocation Term Trust Increases Dividend

The firm also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be issued a $0.2871 dividend. This represents a $3.45 dividend on an annualized basis and a dividend yield of 21.19%. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date of this dividend is Tuesday, October 15th.

About BlackRock Capital Allocation Term Trust

(Free Report)

See Also

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.